PRINCIPAL FINANCIAL GROUP INC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$7,251,347
-34.0%
452,079
-4.6%
0.01%
-37.5%
Q2 2023$10,982,429
-5.6%
473,789
-5.4%
0.01%0.0%
Q1 2023$11,633,143
+58.2%
500,781
-1.2%
0.01%
+33.3%
Q4 2022$7,354,060
-25.7%
506,827
-2.2%
0.01%
-25.0%
Q3 2022$9,892,000
+0.9%
518,431
-3.9%
0.01%
+14.3%
Q2 2022$9,803,000
-32.3%
539,486
-6.1%
0.01%
-22.2%
Q1 2022$14,477,000
-12.5%
574,498
-4.2%
0.01%
-10.0%
Q4 2021$16,548,000
-20.6%
599,575
-7.2%
0.01%
-28.6%
Q3 2021$20,854,000
+5.3%
645,861
-0.2%
0.01%
+7.7%
Q2 2021$19,798,000
+6.6%
647,426
+6.1%
0.01%0.0%
Q1 2021$18,576,000
+57.4%
610,046
+2.2%
0.01%
+44.4%
Q4 2020$11,802,000
+37.2%
596,821
-9.5%
0.01%
+28.6%
Q3 2020$8,599,000
+20.2%
659,433
+4.5%
0.01%
+16.7%
Q2 2020$7,154,000
-14.8%
630,879
+7.5%
0.01%
-33.3%
Q1 2020$8,401,000
-49.4%
587,040
-3.8%
0.01%
-35.7%
Q4 2019$16,618,000
-7.4%
610,287
-2.6%
0.01%
-12.5%
Q3 2019$17,938,000
+3.9%
626,569
+0.8%
0.02%0.0%
Q2 2019$17,264,000
-17.0%
621,449
-0.9%
0.02%
-15.8%
Q1 2019$20,812,000
+11.0%
626,858
-2.8%
0.02%
-5.0%
Q4 2018$18,748,000
-33.7%
644,908
+4.9%
0.02%
-20.0%
Q3 2018$28,275,000
+29.8%
614,691
+5.4%
0.02%
+25.0%
Q2 2018$21,789,000
+26.3%
583,040
-0.1%
0.02%
+25.0%
Q1 2018$17,249,000
-10.7%
583,702
+3.7%
0.02%
-11.1%
Q4 2017$19,326,000
+1.8%
562,701
+7.2%
0.02%0.0%
Q3 2017$18,985,000
+39.1%
524,735
-0.7%
0.02%
+28.6%
Q2 2017$13,652,000
+34.1%
528,346
-0.3%
0.01%
+16.7%
Q1 2017$10,179,000
+4817.4%
530,148
+4174.4%
0.01%
Q4 2016$207,000
-16.2%
12,403
+3.2%
0.00%
Q3 2016$247,000
-32.1%
12,013
+1.1%
0.00%
-100.0%
Q2 2016$364,000
-20.4%
11,880
-2.6%
0.00%0.0%
Q1 2016$457,000
-11.4%
12,202
+2.1%
0.00%0.0%
Q4 2015$516,000
+15.2%
11,9540.0%0.00%0.0%
Q3 2015$448,000
+10.1%
11,954
-0.2%
0.00%0.0%
Q2 2015$407,000
-36.8%
11,974
-34.1%
0.00%0.0%
Q1 2015$644,000
-25.2%
18,178
-28.1%
0.00%0.0%
Q4 2014$861,000
-20.6%
25,287
-10.1%
0.00%
-50.0%
Q3 2014$1,085,000
-4.8%
28,127
-4.0%
0.00%0.0%
Q2 2014$1,140,000
+13.7%
29,299
-0.1%
0.00%0.0%
Q1 2014$1,003,000
+50.6%
29,338
-7.6%
0.00%
+100.0%
Q4 2013$666,000
-10.7%
31,7590.0%0.00%
-50.0%
Q3 2013$746,000
-31.3%
31,759
-21.5%
0.00%0.0%
Q2 2013$1,086,00040,4330.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders